Investor List:

Top Pharmaceuticals Series A Investors in British Columbia (8)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Jaclyn Ling, Venture Partner at Pioneer Fund
Jaclyn Ling
Pioneer Fund·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Toronto (Ontario)
Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Fashion (Seed), Investors in Human Capital/HRTech (Seed), Investors in Education (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in E-commerce (Seed), Investors in Diagnostics (Seed), Investors in Fashion (Seed), Investors in Human Capital/HRTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Education (Seed), Investors in E-commerce (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Fashion (Series A), Investors in Education (Series A), Investors in Human Capital/HRTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Fashion (Series A), Investors in Diagnostics (Series A), Investors in Human Capital/HRTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Education (Series A), Investors in E-commerce (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Education (Series B), Investors in Fashion (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Human Capital/HRTech (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in E-commerce (Series B), Investors in Fashion (Series B), Investors in Diagnostics (Series B), Investors in Human Capital/HRTech (Series B), Investors in Education (Series B), Investors in Pharmaceuticals (Series B), Investors in E-commerce (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in British Columbia (Other Lists)
Photo of Michelle Doig, Partner at Omega Funds
Michelle Doig
Omega Funds·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Toronto (Ontario)
Photo of Robin Gao, Associate at Sixty Degree Capital
Robin Gao
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Toronto (Ontario)
Photo of Sintia Teichman, Associate at Sixty Degree Capital
Sintia Teichman
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Toronto (Ontario)
Photo of Cheryl Kuai, Associate at Sixty Degree Capital
Cheryl Kuai
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Toronto (Ontario)
Photo of Faiz Jalia, Analyst at Pioneer Fund
Faiz Jalia
Pioneer Fund·Analyst
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Toronto (Ontario)
Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in E-commerce (Pre-seed), Investors in Health IT (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in E-commerce (Pre-seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in E-commerce (Seed), Investors in Marketplaces (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Marketplaces (Seed), Investors in E-commerce (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in Marketplaces (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in E-commerce (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Marketplaces (Series A), Investors in E-commerce (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in British Columbia (Other Lists)
SS
Steve Smail
Vice President
Sweet spot: $200K
Range: $100K - $1.5M
Investors in Toronto (Ontario), Investors in Austin (TX), Investors in Tucson (AZ)
Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Space (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in British Columbia (Other Lists), Investors in Austin (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in New York City (Other Lists)
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Space (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Material Science (Pre-seed), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Drug Delivery (Seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in Generative Tech/AI (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in Diagnostics (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Material Science (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in AI (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Space (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Material Science (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Material Science (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Generative Tech/AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in Drug Delivery (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Generative Tech/AI (Series A), Investors in AI (Series A), Investors in Space (Series A), Investors in Generative Tech/AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Space (Series A), Investors in BioTech (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in DeepTech (Series B), Investors in Generative Tech/AI (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in DeepTech (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Material Science (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Space (Series B), Investors in DeepTech (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Space (Series B), Investors in Generative Tech/AI (Series B), Investors in Diagnostics (Series B), Investors in AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Space (Series B), Investors in BioTech (Series B), Investors in DeepTech (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in British Columbia (Other Lists), Investors in Seattle / Portland (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Get new data & insights delivered to your inbox
Firms investing in this space